CUSIP G7709Q104SHS CLASS ARPRXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
529 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 55.27M | $2.14B | +11.11M | Added |
| 2 | Capital International Investors | 31.10M | $1.20B | +3.89M | Added |
| 3 | Fmr LLC | 26.27M | $1.02B | −1.71M | Reduced |
| 4 | Blackrock, Inc. | 26.19M | $1.01B |
| Reduced |
| 5 | Baillie Gifford & Co | 17.01M | $657.22M | −363.7K | Reduced |
| 6 | Swedbank Ab | 11.94M | $461.44M | −258.1K | Reduced |
| 7 | Adage Capital Partners Gp, L.L.C. | 11.74M | $453.66M | −225.0K | Reduced |
| 8 | State Street Corp | 10.65M | $411.50M | +376.9K | Added |
| 9 | Vanguard Group Inc | 9.93M | $383.87M | −1.00M | Reduced |
| 10 | Geode Capital Management, LLC | 7.72M | $297.47M | +102.4K | Added |
See every fund holding Royalty Pharma PLC, with full quarter-over-quarter share changes.
Unlock all holders